Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

PACB holding history

Pacific Biosciences of California, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PACB overviewAll 13F holders of PACBFull Q2 2026 holdings

Shares (Q2 2026)
4,208,146
Value
$7.07M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of PACB by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,208,146$7.07M<0.1%+570,599+15.7%AddedHolders
Q1 20263,637,547$4.80M<0.1%−800,726−18.0%ReducedHolders
Q4 20254,438,273$8.30M<0.1%+4,438,273NewHolders
Q3 20250$00.0%−32,073−100.0%Sold outHolders
Q2 202532,073$39.8K<0.1%+32,073NewHolders
Q3 20240$00.0%−1,645,499−100.0%Sold outHolders
Q2 20241,645,499$2.25M<0.1%+836,239+103.3%AddedHolders
Q1 2024809,260$3.03M<0.1%+798,405+7,355.2%AddedHolders
Q4 202310,855$106.5K<0.1%−32,282−74.8%ReducedHolders
Q3 202343,137$360.2K<0.1%−678,495−94.0%ReducedHolders
Q2 2023721,632$9.60M<0.1%+106,381+17.3%AddedHolders
Q1 2023615,251$7.12M<0.1%+356,578+137.8%AddedHolders
Q4 2022258,673$2.12M<0.1%+82,812+47.1%AddedHolders
Q3 2022175,861$1.02M<0.1%−2,222,426−92.7%ReducedHolders
Q2 20222,398,287$10.6M<0.1%+1,675,760+231.9%AddedHolders
Q1 2022722,527$6.58M<0.1%−461,687−39.0%ReducedHolders
Q4 20211,184,214$24.2M<0.1%−360,118−23.3%ReducedHolders
Q3 20211,544,332$39.5M0.1%+429,913+38.6%AddedHolders
Q2 20211,114,419$39.0M<0.1%+899,874+419.4%AddedHolders
Q1 2021214,545$7.15M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.